152 related articles for article (PubMed ID: 9816136)
21. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
Taylor DD; Gerçel-Taylor C; Lyons KS; Stanson J; Whiteside TL
Clin Cancer Res; 2003 Nov; 9(14):5113-9. PubMed ID: 14613988
[TBL] [Abstract][Full Text] [Related]
22. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
[TBL] [Abstract][Full Text] [Related]
23. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
Müller D; Lang S; Roskrow M; Wollenberg B
Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
25. [Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].
Han Y; Li CL; Lu L; Zhou CX; Ma WB; Wang DM; Zhang SR
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):158-60. PubMed ID: 15196436
[TBL] [Abstract][Full Text] [Related]
26. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
Yuen MF; Norris S
Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
[TBL] [Abstract][Full Text] [Related]
27. CD3ζ-chain expression of human T lymphocytes is regulated by TNF via Src-like adaptor protein-dependent proteasomal degradation.
Érsek B; Molnár V; Balogh A; Matkó J; Cope AP; Buzás EI; Falus A; Nagy G
J Immunol; 2012 Aug; 189(4):1602-10. PubMed ID: 22798681
[TBL] [Abstract][Full Text] [Related]
28. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
[TBL] [Abstract][Full Text] [Related]
29. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
30. PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired.
Nieland JD; Loviscek K; Kono K; Albain KS; McCall AR; Potkul RK; Fisher SG; Velders MP; Petersson M; Kiessling R; Kast WM
J Immunother; 1998 Jul; 21(4):317-22. PubMed ID: 9672853
[TBL] [Abstract][Full Text] [Related]
31. Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions.
Alaibac M; Pigozzi B; Saponeri A; Belloni-Fortina A; Peserico A
Arch Dermatol Res; 2002 Nov; 294(8):380-2. PubMed ID: 12420108
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
Kuss I; Saito T; Johnson JT; Whiteside TL
Clin Cancer Res; 1999 Feb; 5(2):329-34. PubMed ID: 10037182
[TBL] [Abstract][Full Text] [Related]
33. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
34. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.
Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
Blood Purif; 2008; 26(4):317-21. PubMed ID: 18463433
[TBL] [Abstract][Full Text] [Related]
35. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
36. CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer.
Ishigami S; Natsugoe S; Miyazono F; Tokuda K; Nakajo A; Matsumoto M; Okumura H; Nakashima S; Hokita S; Maruyama I; Aikou T
Anticancer Res; 2004; 24(3b):2123-6. PubMed ID: 15274412
[TBL] [Abstract][Full Text] [Related]
37. HSP-10 in ovarian cancer: expression and suppression of T-cell signaling.
Akyol S; Gercel-Taylor C; Reynolds LC; Taylor DD
Gynecol Oncol; 2006 Jun; 101(3):481-6. PubMed ID: 16386781
[TBL] [Abstract][Full Text] [Related]
38. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
[TBL] [Abstract][Full Text] [Related]
39. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.
Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC
Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588
[TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
